Mais recentes
-
Alta nos acidentes com moto no Rio demanda mais ação da Prefeitura
-
Sob a sombra de Trump: oposição de centro-direita vence eleições na Groenlândia, e nacionalistas avançam, segundo a mídia estatal
-
Spotify distribuiu US$ 10 bilhões em pagamentos em 2024, o maior da história da indústria musical; entenda
-
Carminha, Perpétua, Nazaré e outras vilãs de volta: atrizes vão reviver personagens em comemoração dos 60 anos da Globo
Saúde
-
Celartics Biopharma's dendritic cell-based vaccine against COVID-19 infection found to efficiently produce viral antigen-specific T lymphocytes
Results from ongoing study suggest the major role of Celartics' Cov-DCVax in preventing viral infection of COVID-19 and in controlling progression of the virus-associated diseasesBeijing, May 22, 2020, Celartics Biopharma announced today the filing of a patent application covering a novel dendritic cell (DC)-based vaccine, Cov-DCVax, to fight viral infection of COVID-19. The results, led by Celart
05-22
Detalhes -
Comprimidos da Yiling Pharmaceutical Lianhua Qingwen amplamente utilizados na China contra a epidemia
04-18
Detalhes -
Yiling Pharmaceutical Lianhua Qingwen Capsule helps prevent and control the global epidemic
04-10
Detalhes -
Li Yu, Administration of Traditional Chinese Medicine: Traditional Chinese Medicine Lianhua Qingwen Plays an Important Role in Fighting Against COVID-19
03-21
Detalhes